Patents by Inventor Phillip Kim

Phillip Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140372169
    Abstract: The disclosed embodiments include methods, systems, and articles of manufacture for providing business ratings. The disclosed embodiments include, for example, a system that may be configured to access spending transaction data including at least a unique payor identifier, a payee description, a payee category code, and a postal code. The system may determine a payee identification for the spending transaction data by comparing the spending transaction data to a plurality of known payees having the same payee category code as the spending transaction data. Further, the system may access one or more historical spending transactions matching the payee category code, and generate a business rating score for a payee associated with the determined payee identification based on at least the determined one or more historical spending transactions.
    Type: Application
    Filed: June 18, 2014
    Publication date: December 18, 2014
    Applicant: CAPITAL ONE FINANCIAL CORPORATION
    Inventors: Phillip KIM, Alex HASHA, Jaidev SHERGILL, Homin LEE, Simon FREEDMAN
  • Publication number: 20140349865
    Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: November 26, 2013
    Publication date: November 27, 2014
    Applicant: NESTEC S.A.
    Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
  • Publication number: 20140273006
    Abstract: The present invention provides methods for detecting, measuring and quantitating the expression and activation states of signal transduction analytes in cells such as tumor cells. The invention also provides methods for selecting therapy, optimizing therapy, monitoring therapeutic efficacy, and/or detecting therapeutic resistance. Accordingly, the methods are useful for improving cancer therapy selection and disease monitoring.
    Type: Application
    Filed: June 3, 2014
    Publication date: September 18, 2014
    Inventors: Sharat Singh, Anne Kuller, Tani Ann T. Lee, Saswati Hazrar, Richard Kirkland, Xinjun Liu, Phillip Kim
  • Publication number: 20140187445
    Abstract: The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies.
    Type: Application
    Filed: December 16, 2013
    Publication date: July 3, 2014
    Applicant: NESTEC S.A.
    Inventors: Jeanne Harvey, Sharat Singh, Phillip Kim, Xinjun Liu, Robert Barham, Limin Liu
  • Publication number: 20140099300
    Abstract: The present invention provides assays and methods for predicting the post-operative survival of a subject having an early stage gastric cancer after tumor surgery. The present invention also provides methods for treating a subject having an early stage gastric cancer by administering a combination therapy tailored to the signal transduction biomarkers that are activated in the cancer. In particular embodiments, the methods of the invention rely on the detection of the activation state or level of a specific combination of signal transducer analytes in a cancer cell obtained from the subject. Thus, the methods of the invention are particularly useful for predicting the survival or prognosis of a subject having an early stage gastric cancer and for guiding both pre- and post-operative treatment decisions by identifying subjects who would benefit from combination therapy as opposed to monotherapy.
    Type: Application
    Filed: October 2, 2013
    Publication date: April 10, 2014
    Applicant: NESTEC S.A.
    Inventors: Phillip Kim, Sharat Singh
  • Patent number: 8658388
    Abstract: The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: February 25, 2014
    Assignee: Nestec S.A.
    Inventors: Jeanne Harvey, Sharat Singh, Phillip Kim, Xinjun Liu, Robert Barham, Limin Liu
  • Patent number: 8609349
    Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: April 4, 2012
    Date of Patent: December 17, 2013
    Assignee: Nestec S.A.
    Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
  • Publication number: 20130324430
    Abstract: The present invention provides methods for selecting a suitable anticancer drug therapy, and for identifying and predicting response, for the treatment of colorectal cancer. The present invention also provides methods for monitoring the status of colorectal cancer and monitoring how a patient with colorectal cancer is responding to anticancer drug therapy. The present invention further provides methods for the rational selection of therapy with one or more anticancer drugs tailored to target signal transduction pathway components with dysregulated expression and/or activation levels in patients with somatic mutations in an oncogene.
    Type: Application
    Filed: March 13, 2013
    Publication date: December 5, 2013
    Inventors: Phillip Kim, Sharat Singh
  • Publication number: 20130237436
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
    Type: Application
    Filed: January 26, 2011
    Publication date: September 12, 2013
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo
  • Publication number: 20130045880
    Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: April 4, 2012
    Publication date: February 21, 2013
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
  • Publication number: 20130012407
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation levels of components of signal transduction pathways in tumor cells such as triple-negative metastatic breast tumor cells. Information on the expression and/or activation levels of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: July 10, 2012
    Publication date: January 10, 2013
    Applicant: Nestec S.A.
    Inventors: Xinjun Liu, Phillip Kim, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Publication number: 20120270745
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a gastric cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from an ascites sample. The present invention also provides methods for selecting a suitable anticancer therapy and for identifying and predicting response for the treatment of a lung cancer such as a non-small cell lung cancer by determining the expression level and/or activation level of one or more analytes in a cell such as a cancer cell from a pleural efflux sample.
    Type: Application
    Filed: January 19, 2012
    Publication date: October 25, 2012
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo, Limin Liu
  • Publication number: 20120231965
    Abstract: The present invention provides methods for selecting a suitable anticancer drug therapy, and for identifying and predicting response, for the treatment of colorectal cancer. The present invention also provides methods for monitoring the status of colorectal cancer and monitoring how a patient with colorectal cancer is responding to anticancer drug therapy.
    Type: Application
    Filed: February 3, 2012
    Publication date: September 13, 2012
    Applicant: Prometheus Laboratories Inc.
    Inventors: Phillip Kim, Sharat Singh
  • Patent number: 8163499
    Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Grant
    Filed: July 28, 2009
    Date of Patent: April 24, 2012
    Assignee: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
  • Publication number: 20110281748
    Abstract: The present invention provides methods for selecting a suitable anticancer therapy, and for identifying and predicting response for the treatment of a gastric cancer.
    Type: Application
    Filed: January 26, 2011
    Publication date: November 17, 2011
    Applicant: Prometheus Laboratories Inc.
    Inventors: Sharat Singh, Phillip Kim, Xinjun Liu, Belen Ybarrondo
  • Publication number: 20110071042
    Abstract: The present invention provides compositions and methods for detecting the expression and/or activation states of components of signal transduction pathways in cells such as tumor cells. Information on the expression and/or activation states of components of signal transduction pathways derived from use of the present invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: August 10, 2010
    Publication date: March 24, 2011
    Applicant: Prometheus Laboratories Inc.
    Inventors: Phillip Kim, Xinjun Liu, Richard Kirkland, Tani Lee, Belen Ybarrondo, Sharat Singh
  • Publication number: 20100167945
    Abstract: The present invention provides compositions and methods for detecting the activation states of components of signal transduction pathways in tumor cells. Information on the activation states of components of signal transduction pathways derived from use of the invention can be used for cancer diagnosis, prognosis, and in the design of cancer treatments.
    Type: Application
    Filed: July 28, 2009
    Publication date: July 1, 2010
    Applicant: Prometheus Laboratories, Inc.
    Inventors: Sharat Singh, Jeanne Harvey, Phillip Kim, Xinjun Liu, Limin Liu, Robert Barham, Bruce Neri
  • Publication number: 20080311568
    Abstract: Contemplated methods and kits include a plurality of single stranded oligonucleotides that comprise a discriminating sequence that is encompassed on one end by a label and on the other end by a unique tag sequence. In one preferred aspect, the discriminating sequence is an RNA repeat unit, forms a heteroduplex with a complementary DNA repeat unit of the target nucleic acid, and the discriminating agent is RNaseH. Using such systems, the number of repeat units can be simply identified by hydrolysis of the discriminating sequence where such sequence is adjacent to a predetermined number of DNA repeat units in the single stranded oligonucleotide.
    Type: Application
    Filed: December 12, 2005
    Publication date: December 18, 2008
    Applicant: AUTOGENOMICS, INC.
    Inventors: Phillip Kim, Vijay Mahant
  • Publication number: 20080261829
    Abstract: The present invention provides antibody-based arrays for detecting the activation state and/or total amount of a plurality of signal transduction molecules in rare circulating cells and methods of use thereof for facilitating cancer prognosis and diagnosis and the design of personalized, targeted therapies.
    Type: Application
    Filed: March 11, 2008
    Publication date: October 23, 2008
    Applicant: Prometheus Laboratories Inc.
    Inventors: Jeanne Harvey, Sharat Singh, Phillip Kim, Xinjun Liu, Robert Barham, Limin Liu